Reovirus/Gemcitabine Combination Has Synergistic Effect Against Human Colon Cancer Cell Lines
Colon Cancer Treatment
Oncolytics Biotech Inc. announces that a poster by Dr. Maureen E. Lane entitled "In Vivo Synergy between Oncolytic Reovirus and Gemcitabine in Ras-Mutated Human HCT116 Xenografts" is scheduled to be presented
Share this content.
If you liked this article and think it may help your friends, consider sharing or tweeting it to your followers.